Clinical Trial Update: Rimegepant Combined With AG Chemotherapy As First-Line Treatment For Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical trial update evaluating rimegepant in combination with AG chemotherapy as first-line therapy for metastatic pancreatic ductal adeno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• AG chemotherapy
• Rimegepant (rimegepant)

Snippet

Sponsor: Xiuchao Wang | Conditions: Metastatic Pancreatic Ductal Adenocarcinoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING